P

Inventor

SHIN YOUNG JUN

KR48 patents
⚠️ This page may combine multiple inventors who share the name “SHIN YOUNG JUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARENA PHARM INC

13 patents
US7132426B2Nov 7, 2006

Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC56 citations95
US7838525B2Nov 23, 2010

Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC39 citations92
US7470699B2Dec 30, 2008

Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC41 citations92
US9012478B2Apr 21, 2015

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC4 citations83
US7625906B2Dec 1, 2009

Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC11 citations83
US11098034B2Aug 24, 2021

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC1 citations72
US10689372B2Jun 23, 2020

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC1 citations72
US10214518B2Feb 26, 2019

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC2 citations72
US9663500B2May 30, 2017

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC3 citations72
US11339172B2May 24, 2022

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto

ARENA PHARM INC3 citations70
US10668033B2Jun 2, 2020

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC4 citations70
US11987588B2May 21, 2024

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto

ARENA PHARM INC0 citations60
USRE50267EJan 14, 2025

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

ARENA PHARM INC0 citations59

SAMSUNG DISPLAY CO LTD

10 patents

DOOSAN ENERBILITY CO LTD

7 patents

III HOLDINGS 1 LLC

4 patents

LEE JAE-JUN

2 patents

JONES ROBERT M

2 patents

LG CHEMICAL LTD

2 patents

NAT UNIV SINGAPORE

2 patents

KT FREETEL CO LTD

1 patent

TRAN THUY-ANH

1 patent

KT CORP

1 patent

ARISAN THERAPEUTICS INC

1 patent

CHEIL FOODS & CHEM

1 patent

INNOCURE THERAPEUTICS INC

1 patent